Reborne Longevity B-Cube Onco Test: The Blood Test That Can Spot Cancer Before It Starts

When it comes to cancer, one fact is clear: the earlier it’s found, the better the outcome. Across eight of the most common cancers, research shows that 10-year survival rates are over 90% when the disease is diagnosed at stage 1. Once it spreads to stage 4, survival drops to around 5%.

The challenge? Most cancers don’t announce themselves early. Symptoms often appear only once the disease has already progressed. That’s why at Reborne Longevity, we’re proud to introduce the B‑Cube  Onco (Onco B³) test—a next-generation, non-invasive blood test that can reveal cancer risk years before traditional methods.

What Is the B-Cube Onco Cancer Blood Test?

B-Cube Onco is an advanced cancer screening blood test that looks for the earliest cellular changes linked to cancer. It focuses on a rare group of cells in your bloodstream called very small embryonic-like stem cells (VSELs). Under certain conditions, these cells can transform into cancer stem cells (CSCs)—the starting point of tumours.

Once these cells are isolated, the test uses next-generation sequencing (NGS) to study their RNA—the genetic instructions that show which pathways are behaving normally and which ones are veering off course. The result is a whole-body cancer risk map from a single blood draw.

Why B-Cube Onco Is Different

Traditional screening tools like mammograms, colonoscopies, or CT scans remain critical—but they tend to focus on one organ at a time and often detect cancer only once it’s visible.

B-Cube Onco works differently:

• Whole-body coverage – It looks at multiple organ systems in one go.

• Earlier insights – It identifies cancer stem cells before tumors form.

• Actionable results – You and your doctor get a personalised, risk-scored report that highlights which pathways are disrupted.

• Easier monitoring – Because it’s just a blood test, it can be repeated over time to track remission or treatment response..

Why We’re Offering It at Our Wellness Clinic

At Reborne Longevity, we exist to bring the world’s most advanced diagnostics and therapies together under one roof. Many of these tools—like the Human Regenerator Jet or our Basecamp programme—are not available anywhere else in the UK.

B-Cube Onco fits perfectly into that mission. It’s not just another test; it’s a shift in how we approach cancer care. By moving detection upstream, we’re giving our members a chance to act earlier, make more informed choices, and protect their long-term health. At our Harley Street clinic, it’s about empowerment. A simple blood test that can spot the earliest signs of cancer isn’t just technology—it’s peace of mind.

The Bigger Picture

The World Health Organisation estimates that up to half of all cancers are preventable, often through lifestyle changes and early detection. Tools like B-Cube Onco help close the gap by making proactive cancer screening more accessible, less invasive, and easier to repeat.

We believe this is the future of medicine: shifting from treating disease to preventing it.

Final Thoughts

The Reborne Longevity B-Cube Onco test is more than a diagnostic—it’s a window into your future health. With one blood draw, it can:

• Catch cancer risk at its earliest molecular stage

• Provide a whole-body scan without surgery or radiation

• Give doctors actionable insights to guide care

• Offer ongoing reassurance through repeat testing

  
  

At Reborne Longevity, we’re proud to make this breakthrough available to our members. Because when it comes to cancer, the earlier we act, the longer we live well.